{"entity":{"type":"insider","cik":"0001614975","url":"/insider/0001614975","json_url":"/insider/0001614975.json","name":"Smith Scott Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":8,"first":"2019-06-28","last":"2025-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Smith Scott Andrew","source":"filing","n_filings":8,"first_seen":"2019-06-28","last_seen":"2025-08-13"}],"transactions":[{"id":4700437,"accession":"0001140361-25-030884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-030884","line_url":"/filing/0001140361-25-030884#line-1","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"Viatris Inc","issuer_ticker":"VTRS","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":9.9882,"price_display":"9.99","price_state":"stated","total_value":219740.4,"total_display":"219,740.40","total_whole":"219,740","shares_owned_after":314807.0,"shares_owned_after_display":"314,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4905133,"accession":"0001140361-25-019026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-019026","line_url":"/filing/0001140361-25-019026#line-1","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"Viatris Inc","issuer_ticker":"VTRS","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":8.9377,"price_display":"8.94","price_state":"stated","total_value":536262.0,"total_display":"536,262.00","total_whole":"536,262","shares_owned_after":292807.0,"shares_owned_after_display":"292,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":4747032,"accession":"0001209191-21-068385","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-068385","line_url":"/filing/0001209191-21-068385","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2984.0,"shares_display":"2,984","price_per_share":21.7554336461126,"price_display":"21.76","price_state":"stated","total_value":64918.214,"total_display":"64,918.21","total_whole":"64,918","shares_owned_after":345715.0,"shares_owned_after_display":"345,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-07","scope":"insider","n_lines":2},{"id":4747022,"accession":"0001209191-21-068385","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-068385","line_url":"/filing/0001209191-21-068385","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":628.0,"shares_display":"628","price_per_share":23.034547770700637,"price_display":"23.03","price_state":"stated","total_value":14465.696,"total_display":"14,465.70","total_whole":"14,466","shares_owned_after":348716.0,"shares_owned_after_display":"348,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-07","scope":"insider","n_lines":3},{"id":4747008,"accession":"0001209191-21-068385","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-068385","line_url":"/filing/0001209191-21-068385","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":478.0,"shares_display":"478","price_per_share":24.50925523012552,"price_display":"24.51","price_state":"stated","total_value":11715.424,"total_display":"11,715.42","total_whole":"11,715","shares_owned_after":349342.0,"shares_owned_after_display":"349,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-07","scope":"insider","n_lines":3},{"id":5348631,"accession":"0001209191-21-068213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-068213","line_url":"/filing/0001209191-21-068213#line-1","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":23.89,"price_display":"23.89","price_state":"stated","total_value":9532.11,"total_display":"9,532.11","total_whole":"9,532","shares_owned_after":349746.0,"shares_owned_after_display":"349,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-06","scope":"insider"},{"id":4344578,"accession":"0001209191-21-067219","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-067219","line_url":"/filing/0001209191-21-067219","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":466.0,"shares_display":"466","price_per_share":24.868137339055792,"price_display":"24.87","price_state":"stated","total_value":11588.552,"total_display":"11,588.55","total_whole":"11,589","shares_owned_after":350438.0,"shares_owned_after_display":"350,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-30","scope":"insider","n_lines":3},{"id":4344568,"accession":"0001209191-21-067219","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-067219","line_url":"/filing/0001209191-21-067219","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":684.0,"shares_display":"684","price_per_share":24.92206140350877,"price_display":"24.92","price_state":"stated","total_value":17046.69,"total_display":"17,046.69","total_whole":"17,047","shares_owned_after":350860.0,"shares_owned_after_display":"350,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":4344561,"accession":"0001209191-21-067219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067219","line_url":"/filing/0001209191-21-067219#line-1","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":26.235,"price_display":"26.24","price_state":"stated","total_value":11281.05,"total_display":"11,281.05","total_whole":"11,281","shares_owned_after":351295.0,"shares_owned_after_display":"351,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-30","scope":"insider"},{"id":4902877,"accession":"0001209191-21-059977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059977","line_url":"/filing/0001209191-21-059977#line-1","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2994.0,"shares_display":"2,994","price_per_share":30.1775,"price_display":"30.18","price_state":"stated","total_value":90351.435,"total_display":"90,351.44","total_whole":"90,351","shares_owned_after":351725.0,"shares_owned_after_display":"351,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-07","scope":"insider"},{"id":5381584,"accession":"0001209191-21-053994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053994","line_url":"/filing/0001209191-21-053994","is_derivative":false,"issuer_cik":"0001614975","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001614975","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33244.0,"shares_display":"33,244","price_per_share":40.155424578871376,"price_display":"40.16","price_state":"stated","total_value":1334926.9347,"total_display":"1,334,926.93","total_whole":"1,334,927","shares_owned_after":368568.0,"shares_owned_after_display":"368,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-30","scope":"insider","n_lines":2},{"id":8298283,"accession":"0001209191-19-039454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039454","line_url":"/filing/0001209191-19-039454#line-1","is_derivative":false,"issuer_cik":"0001566373","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001566373","owner_cik":"0001614975","owner_name":"Smith Scott Andrew","owner_display_name":"Smith Scott Andrew","owner_url":"/insider/0001614975","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":4.09,"price_display":"4.09","price_state":"stated","total_value":49080.0,"total_display":"49,080.00","total_whole":"49,080","shares_owned_after":13883.0,"shares_owned_after_display":"13,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-06-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001792044","name":"Viatris Inc","url":"/issuer/0001792044","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2025-05-14","last_seen":"2025-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001826892","name":"BioAtla, Inc.","url":"/issuer/0001826892","role":"Director, Officer (President)","n_filings":5,"first_seen":"2021-08-30","last_seen":"2021-12-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001566373","name":"Spring Bank Pharmaceuticals, Inc.","url":"/issuer/0001566373","role":"Director","n_filings":1,"first_seen":"2019-06-28","last_seen":"2019-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614975","retrieved_at":"2026-08-24T09:34:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}